SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-14-003313
Filing Date
2014-10-14
Accepted
2014-10-14 08:34:04
Documents
12
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 form10k.htm 10-K 1073559
2 ex-21.htm EX-21 3110
3 ex23-1.htm EX-23.1 4827
4 ex31-1.htm EX-31.1 15524
5 ex31-2.htm EX-31.2 15395
6 ex-32.htm EX-32 8956
  Complete submission text file 0001493152-14-003313.txt   6548578

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE corx-20121231.xml EX-101.INS 798369
8 XBRL SCHEMA FILE corx-20121231.xsd EX-101.SCH 69167
9 XBRL CALCULATION FILE corx-20121231_cal.xml EX-101.CAL 65483
10 XBRL DEFINITION FILE corx-20121231_def.xml EX-101.DEF 232763
11 XBRL LABEL FILE corx-20121231_lab.xml EX-101.LAB 467734
12 XBRL PRESENTATION FILE corx-20121231_pre.xml EX-101.PRE 330873
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16467 | Film No.: 141153856
SIC: 2834 Pharmaceutical Preparations